News

The world-renowned meeting offers in-person and virtual access to the latest science on arrhythmia care, digital health, and novel technologies.

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced the appointment of Stephan Ogilvie as its Chief Financial Officer. Mr. Ogilvie's career spans decades...

DEFINE AFib Study Will Leverage Data from Medtronic Insertable Cardiac Monitors and Medtronic Discovery App™ with the Goal of Informing Atrial Fibrillation (AF) Management Strategies

Presentation to highlight clinical applications of the Company’s latest software for arrhythmia care

by Anna Jones June 28, 2021 — Investigations by researchers at UAB reveal the existence of a day-night rhythm of heart hormones, and how the disturbance of this rhythm could contribute to a high risk of high blood pressure and poor...

Acquisition complements company's electrophysiology portfolio to include the only commercially available cardiac pulsed field ablation technology

OMRON Healthcare Co., Ltd. and Kyoto University announced a new Collaborative Research Program called “Healthcare Medical AI” to use artificial intelligence and an innovative data set of home measurements to prevent the events of...

Application seeks two pediatric indications, including an age-appropriate new weight-based oral suspension formulation to help minimize dosing errors If approved, XARELTO® will be the first and only oral Factor Xa inhibitor indicated in...

Abstracts are due to be presented by physician users and research investigators from two leading institutions

- First and Only Approval to Indicate Cryoablation as an Initial Rhythm Control Strategy; - Offers Safe, Effective Alternative to Antiarrhythmic Drug Therapy for the Prevention of Atrial Arrhythmia Recurrence